See What's Inside
Read this FREE issue now
For healthcare professionals only

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter

Health

Page 3
CDC Predicts 40% of American Adults Will Develop Diabetes
Sep 15, 2014 | 
Based on a statistical analysis of almost 600,000 American Adults in three studies, the Centers for Disease Control estimates that 40 percent of all U.S. adults 20 years or older will develop type 2 diabetes in their lives. (The risk for men was estimated at 40.2 percent and for women, 39.6 percent.)For Hispanic men and women and non-Hispanic black women, the statistical risk is higher: more than 50 percent.
U.S. Trails Two Dozen Other Nations In Physicians Per Capita
Sep 11, 2014 | 
Two dozen other countries top the United States when it comes to having enough doctors to go around.
DHTV
Popular
Top Rated

Related Community Videos on Diabetes Health TV

Injection Site Awareness Week

Dr. Stuart Bootle, MB ChB

Injection Site Awareness Week

First Look:  New iPhone App for Logging Readings and Much More

Hadi El Heneidi - Agamatrix

First Look: New iPhone App for Logging Readings and Much More

Medtronic Diabetes

Courtney Parkin

Medtronic Diabetes

FDA Lifts Restrictions on Patient Access to Avandia
Aug 7, 2014 | 
The type 2-diabetes drug Avandia will again be available through retail pharmacies after a May ruling by the U.S. Food and Drug Administration.

The drug - a rosiglitazone-based medicine that controls blood glucose by increasing the body’s sensitivity to insulin, so cells and muscles are able to use more for energy, reducing levels in the blood - was off the market in Europe and restricted in the United States for several years due to studies showing the drug raised the risk of heart disease. The FDA in 2013 reversed its earlier opinion and lifted restrictions on the drug, opening the doors for Avandia’s return to market.

Initially released in 1999, Avandia had been one of Glaxo's top-selling medicines, with sales of $3.2 billion in 2006. Sales tanked in 2010 after a review of clinical trials showed an increased risk of heart attack related to the drug – those taking the drug in the United States dropped from 120,000 to 3,000 – but last year, new trials showed no elevated risk of heart attack or death in patients being treated with Avandia compared to other diabetes drugs, causing the FDA to reverse its opinion.

“GSK welcomes the decision of the FDA and appreciates the agency’s robust review of the science about Avandia,” Glaxo said in a statement last year. “GSK maintains its view that Avandia is a safe and effective treatment for Type 2 diabetes when used appropriately.”

While the drug had previously been available only through specialty pharmacies and the patients already taking the drug or whose symptoms were not adequately controlled by other drugs, the new FDA ruling allows all patient's access to Avandia, Avandamet and Avandaryl. All of these medications contain rosiglitazone.

“Our actions reflect the most current scientific knowledge about the risks and benefits of this drug,” Janet Woodcock, director of the FDA's Center for Drug Evaluation and Research, said in a statement last year. “Given these new results, our level of concern is considerably reduced; thus, we require the removal of certain prescribing restrictions.”

While the drug’s manufacturer, GlaxoSmithKline, has a marketing hurdle to overcome given the bad press the drug has received over the last few years, the British drug maker has no plans to promote Avandia in the United States, in part because its U.S. patent protection lapsed in 2011.
The drug will be available by prescription.

To assist in the transition, a toll-free telephone number has been established for patients, healthcare professionals and pharmacies - 1-800-282-6342 – which will be staffed from 8;30 a.m. to 5 p.m. Monday through Friday Eastern Time.
These Microwaves Don't Just Heat, They Count Calories
Aug 6, 2014 | 
Microwaves: From carrying TV images to warming up coffee or thawing a chicken pot pie, is there anything they can't do? Probably not. Because it turns out that microwaves may soon allow us to determine the calories in the food, we eat at home simply by sliding it onto a device that measures calories using a microwave bombardment. The microwaves give a reading of the potential energy in the food and translate it into a calorie count.
Insulin pumps lead to lower A1C levels for insulin-dependent type 2s
Aug 2, 2014 | 
Insulin pumps can be as beneficial for those with type 2 diabetes that require insulin as they have become for those with type 1, according to a new trial.
What Type 2s Can Do When Blood Sugar Soars
Jul 16, 2014 | 
The emergency condition most type 2s dread is hypoglycemia, where plummeting blood sugar levels can bring on a dangerous semi-conscious state, and even coma or death.
FDA Delays Decision on Inhaled Insulin
May 24, 2014 | 
The Food and Drug Administration (FDA) has delayed until July 15th making a decision on whether to allow the inhaled insulin Afrezza entry into the American market.
Next Page » « Previous Page
©1991-2014 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.